
Radformation
Radformation: Innovating efficient, error-reducing software for radiation oncology cancer treatment planning.

Radformation: Innovating efficient, error-reducing software for radiation oncology cancer treatment planning.
Radformation was founded by a team of clinical physicists with the core mission of increasing efficiency and reducing errors in radiation oncology cancer treatment planning. The company offers innovative software solutions designed to automate and streamline various stages of the treatment planning process, including contouring, planning, and quality assurance. Their products aim to enhance plan quality, safety, and overall departmental efficiency, allowing cancer clinics to focus more on patient care.
Notable affiliated individuals include the founding team of clinical physicists who bring extensive expertise in radiation oncology. Radformation has received investments from prominent venture capital firms specializing in healthcare technology. Key achievements include the successful deployment of their software in numerous cancer treatment centers, significantly improving workflow and reducing planning time. The overall impact of Radformation's solutions is seen in enhanced treatment accuracy and increased capacity for clinics to manage complex cases efficiently.
Companies similar to Radformation include Radialogica, Infondrian, OncoLens and Quantaras.
Radformation was founded in 2016.
Radformation's headquarters is located in New York City, NY, US.
Radformation's most recent funding round was for $6.9M (USD) in May 2023.
As of May 25, 2023, Radformation has disclosed funding of $8.5M (USD). Undisclosed round amounts are excluded.
Radformation has 119 employees as of Feb 5, 2024.

Quantaras
quantaras.com